Clinical trials: Vital Sign Evaluation
- Condition Vital Sign Evaluation
- Funder type Industry (pharma, biotech, devices)
- Age group Children (under 18)
Vital Sign Monitoring
Pilot Clinical Evaluation of the RHEA Vital Sign Vigilance System in Hospital Patients Patients
This study comparing both of the investigational device and reference device to gold standard Patient Monitor of the accuracy of heart rate and respiratory rate monitoring.
- Trial name
- NCT03269643
- Testing
- Investigational Group, Reference group
- Where
- United States
- Volunteers
- 15 people
- Sponsor
- Darma Inc.
In-patients Assessment of Vital Signs
Data Collection Study for RFP (Respiration From Plethysmogram)
The study will be conducted in hospitalised patients who undergo spot-check monitoring of vital signs as part of their routine care.
- Trial name
- SAT+ (NCT06633861)
- Testing
- spot-check measurement
- Where
- United Kingdom
- Volunteers
- 86 people
- Sponsor
- Philips Clinical & Medical Affairs Global
Blood Oxygen Desaturations, Sleep-Disordered Breathing
Assessment of the Accuracy of the Non-invasive Wireless Armband Gabi Baby Band for Continuous Vital Parameters Monitoring in Infants and Young Children
During a polysomnography test (PSG) previously prescribed by a physician, the patient also wears the Gaby Baby Band (GBB) during an entire night of sleep.
- Trial name
- WAGSC1 (NCT04886583)
- Testing
- Gabi Baby Band
- Where
- 3 sites in Belgium
- Volunteers
- 99 people, healthy volunteers welcome
- Sponsor
- Gabi SmartCare
Vital Sign Monitoring
Pilot Clinical Evaluation of the RHEA Vital Sign Vigilance System in Hospital Patients
This study comparing both of the investigational device and reference device to gold standard Patient Monitor of the accuracy of heart rate and respiratory rate monitoring.
- Trial name
- NCT03257956
- Testing
- Investigational Group, reference group
- Where
- United States
- Volunteers
- 15 people
- Sponsor
- Darma Inc.
Vital Sign Monitoring
Pilot Clinical Evaluation of the RHEA Vital Sign Vigilance System in Hospital Patients
This study compares both of the investigational device and reference device to the gold standard Patient Monitor of the accuracy of heart rate and respiratory rate monitoring.
- Trial name
- NCT03356184
- Testing
- The Rhea Vital Sign Vigilance Device Group, The Earlysense System Device Group
- Where
- United States
- Volunteers
- 5 people
- Sponsor
- Darma Inc.
Malignant Glioma
Post-Marketing Surveillance of Long-Term Observation of Gliadel Wafer-Investigation of Vital Prognosis in Patients With High Grade Glioma
The objective of this study is to determine the survival status of patients enrolled in study GLI01S (all-case observational study).
- Trial name
- NCT02300506
- Testing
- No intervention
- Where
- 2 sites in Japan
- Volunteers
- 507 people
- Sponsor
- Eisai Co., Ltd.
Vital Sign Monitoring
Clinical Evaluation of the RHEA Vital Sign Vigilance System in Hospital Patients Patients
This study compares both of the investigational device and reference device to the gold standard Patient Monitor of the accuracy of heart rate and respiratory rate monitoring.
- Trial name
- NCT03332147
- Testing
- Investigational Group, reference group-Earlysense system
- Where
- 3 sites in United States
- Volunteers
- 80 people
- Sponsor
- Darma Inc.
Sudden Cardiac Arrest, Emergency Care
Tempus Pro Monitor Registry
A multicenter, prospective and retrospective, observational, post market study.
- Trial name
- NCT05587764
- Testing
- Standard of Care
- Where
- United States
- Volunteers
- 103 people
- Sponsor
- Heartstream US LLC